GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2012

Zealand Pharma, Protagonist to Develop Disulfide-Rich Peptide Therapeutics

  • Zealand Pharma and Protagonist Therapeutics signed a collaboration agreement focused on the discovery and development of disulfide-rich peptide  (DRP)-based therapeutics against targets specified by Zealand. The partnership will hinge on Protagonist’s technology platform for the discovery and optimization of DRPs that exhibit increased stability and thus improved pharmacokinetic profiles.

    Under terms of the deal Zealand retains all rights to all resulting DRP drug candidates and will be responsible for all preclinical and clinical development. Protagonist will receive an up-front fee along with preclinical, clinical, and sales milestones. The firm in addition retains an option to co-finance the development of DRP drug candidates.

    Protagonist is exploiting DRPs as a broad scaffold class and has assembled a database of over 5,000 experimentally derived DRPs that can be further optimized and functionalized against virtually any specified target including those traditionally addressed by mAbs or targets such as GPCRs, ion channels, and chemokines that are generally intractable to mAbs.

    The firm claims optimized DRP molecules are highly constrained and stable chemical entities that effectively combine the beneficial features of mAb drugs with the desired properties of small molecule drugs. The resulting attributes include improved oral stability, reduced immunogenicity, favorable pharmacokinetics, improved distribution and tissue penetration, and delivery by injectable and/or oral routes.

    Protagonist’s in-house R&D is focused on developing injectable and orally stable IL-6 peptide antagonists. The firm also has an ongoing collaboration with Ironwood Pharmaceuticals to develop DRP candidates against its partner’s targets.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »